B854 Pill - yellow round
Pill with imprint B854 is Yellow, Round and has been identified as Repaglinide 1 mg. It is supplied by Breckenridge Pharmaceutical, Inc.
Repaglinide is used in the treatment of Diabetes, Type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B854
Repaglinide
- Imprint
- B854
- Strength
- 1 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Meglitinides
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC)
- 51991-0854 (Discontinued)
- Inactive Ingredients
-
microcrystalline cellulose,
polacrilin potassium,
povidone k30,
magnesium stearate,
poloxamer 407,
calcium phosphate dibasic anhydrous,
ferric oxide yellow
Note: Inactive ingredients may vary.
More about repaglinide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (12)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: meglitinides
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.